Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Tytuł pozycji:

Effects of neuro-adaptive electrostimulation therapy on pain and disability in fibromyalgia: A prospective, randomized, double-blind study.

Tytuł:
Effects of neuro-adaptive electrostimulation therapy on pain and disability in fibromyalgia: A prospective, randomized, double-blind study.
Autorzy:
Udina-Cortés C; Institute Neurolife.
Fernández-Carnero J; Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, University Rey Juan Carlos.; La Paz Hospital Institute for Health Research (IdiPAZ).; Motion in Brains Research Group, Institute of Neuroscience and Movement Sciences, Centro Superior de Estudios Universitarios La Salle, Universidad Autonoma de Madrid.
Romano AA; Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, University Rey Juan Carlos.
Cuenca-Zaldívar JN; School of Health Sciences, University Francisco de Vitoria, Madrid, Spain.
Villafañe JH; IRCCS Fondazione Don Carlo Gnocchi, Milan, Italy.
Castro-Marrero J; Vall d'Hebron Hospital Research Institute, Division of Rheumatology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Alguacil-Diego IM; Department of Physical Therapy, Occupational Therapy, Rehabilitation and Physical Medicine, University Rey Juan Carlos.
Źródło:
Medicine [Medicine (Baltimore)] 2020 Dec 18; Vol. 99 (51), pp. e23785.
Typ publikacji:
Journal Article; Randomized Controlled Trial
Język:
English
Imprint Name(s):
Original Publication: Hagerstown, Md : Lippincott Williams & Wilkins
MeSH Terms:
Electric Stimulation Therapy/*methods
Fibromyalgia/*therapy
Adult ; Analysis of Variance ; Cohort Studies ; Disabled Persons/psychology ; Double-Blind Method ; Electric Stimulation Therapy/standards ; Electric Stimulation Therapy/statistics & numerical data ; Female ; Fibromyalgia/complications ; Fibromyalgia/physiopathology ; Humans ; Middle Aged ; Pain/etiology ; Pain Management/methods ; Pain Measurement/methods ; Placebos/therapeutic use ; Prospective Studies ; Spain/epidemiology ; Surveys and Questionnaires ; Treatment Outcome
References:
Wolfe F, Clauw DJ, Fitzcharles MA, et al. The American College of Rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 2010;62:600–10.
Jones J, Rutledge DN, Jones KD, et al. Self-assessed physical function levels of women with fibromyalgia: a national survey. Womens Health Issues 2008;18:406–12.
Queiroz LP. Worldwide epidemiology of fibromyalgia. Curr Pain Headache Rep 2013;17:356doi: 10.1007/s11916-013-0356-5. (PMID: 10.1007/s11916-013-0356-5)
Petersel DL, Dror V, Cheung R. Central amplification and fibromyalgia: disorder of pain processing. J Neurosci Res 2011;89:29–34.
Jensen KB, Kosek E, Petzke F, et al. Evidence of dysfunctional pain inhibition in fibromyalgia reflected in rACC during provoked pain. Pain 2009;144:95–100.
Ayan D, Roy J, Maltais R, et al. Impact of estradiol structural modifications (18-methyl and/or 17-hydroxy inversion of configuration) on the in vitro and in vivo estrogenic activity. J Steroid Biochem Mol Biol 2011;127:324–30.
DeSantana JM, Da Silva LF, De Resende MA, et al. Transcutaneous electrical nerve stimulation at both high and low frequencies activates ventrolateral periaqueductal grey to decrease mechanical hyperalgesia in arthritic rats. Neuroscience 2009;163:1233–41.
Johnson MI, Claydon LS, Herbison GP, et al. Transcutaneous electrical nerve stimulation (TENS) for fibromyalgia in adults. Cochrane Database Syst Rev 2017;10:CD012172doi: 10.1002/14651858.CD012172.pub2. (PMID: 10.1002/14651858.CD012172.pub2)
Deus-Yela J, Soler MD, Pelayo-Vergara R, et al. Transcranial direct current stimulation for the treatment of fibromyalgia: a systematic review. Rev Neurol 2017;65:353–60.
Schabrun SM, Cannan A, Mullens R, et al. The effect of interactive neurostimulation therapy on myofascial trigger points associated with mechanical neck pain: a preliminary randomized, sham-controlled trial. J Altern Complement Med 2012;18:946–52.
Selfe TK, Bourguignon C, Taylor AG. Effects of noninvasive interactive neurostimulation on symptoms of osteoarthritis of the knee: a randomized, sham-controlled pilot study. J Altern Complement Med 2008;14:1075–81.
Villafane JH, Valdes K, Imperio G, et al. Neural manual vs. robotic assisted mobilization to improve motion and reduce pain hypersensitivity in hand osteoarthritis: study protocol for a randomized controlled trial. J Phys Ther Sci 2017;29:801–6.
Pedersini P, Valdes K, Cantero-Tellez R, et al. The effects of neurodynamic mobilizations on pain hypersensitivity in patients with hand osteoarthritis compared to robotic assisted mobilization: a randomized clinical trial. Arthritis Care Res (Hoboken) 2019;doi: 10.1002/acr.24103. Online ahead of print. (PMID: 10.1002/acr.24103.)
Kamper SJ, Maher CG, Hush JM, et al. Relationship between pressure pain thresholds and pain ratings in patients with whiplash-associated disorders. Clin J Pain 2011;27:495–501.
Villafane JH, Cleland JA, Fernandez-de-Las-Penas C. Bilateral sensory effects of unilateral passive accessory mobilization in patients with thumb carpometacarpal osteoarthritis. J Manipulative Physiol Ther 2013;36:232–7.
Cathcart S, Winefield AH, Rolan P, et al. Reliability of temporal summation and diffuse noxious inhibitory control. Pain Res Manag 2009;14:433–8.
Rivera J, Gonzalez T. The Fibromyalgia Impact Questionnaire: a validated Spanish version to assess the health status in women with fibromyalgia. Clin Exp Rheumatol 2004;22:554–60.
Vilagut G, Ferrer M, Rajmil L, et al. The Spanish version of the Short Form 36 Health Survey: a decade of experience and new developments. Gac Sanit 2005;19:135–50.
Crawford BK, Piault EC, Lai C, et al. Assessing sleep in fibromyalgia: investigation of an alternative scoring method for the Jenkins Sleep Scale based on data from randomized controlled studies. Clin Exp Rheumatol 2010;28: (Suppl 63): S100–9.
Alvarez-Astorga A, Garcia-Azorin D, Hernandez M, et al. Pain catastrophising in a population of patients with migraine. Neurologia (Barcelona, Spain) 2019;doi: 10.1016/j.nrl.2018.10.005. (PMID: 10.1016/j.nrl.2018.10.005)
Guillén-Riquelme A, Buela-Casal A. Actualización psicométrica y funcionamiento diferencial de los ítems en el State Trait Anxiety Inventory (STAI). Psicothema 2011;23:510–5.
Sanz J, Perdigón AL, Vázquez C. Adaptación española del Inventario para la Depresión de Beck-II (BDI-II): Propiedades psicométricas en población general. Clínica y Salud 2003;14:249–80.
Bunzli S, Smith A, Watkins R, et al. What do people who score highly on the Tampa Scale of Kinesiophobia really believe? A mixed methods investigation in people with chronic nonspecific low back pain. Clin J Pain 2015;31:621–32.
Dworkin RH, Turk DC, McDermott MP, et al. Interpreting the clinical importance of group differences in chronic pain clinical trials: IMMPACT recommendations. Pain 2009;146:238–44.
Dailey DL, Rakel BA, Vance CG, et al. Transcutaneous electrical nerve stimulation reduces pain, fatigue and hyperalgesia while restoring central inhibition in primary fibromyalgia. Pain 2013;154:2554–62.
Han J, Inbo Han I. A Comparative study of the efficacy between self-controlled energo-neuro-adaptive regulator and transcutaneous electrical nerve stimulation for whiplash injury. Nerve 2016;2:33–7.
Bennett RM, Bushmakin AG, Cappelleri JC, et al. Minimal clinically important difference in the fibromyalgia impact questionnaire. J Rheumatol 2009;36:1304–11.
Lauretti GR, Chubaci EF, Mattos AL. Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain. Rheumatol Int 2013;33:2117–22.
Russell IJ, Holman AJ, Swick TJ, et al. Sodium oxybate reduces pain, fatigue, and sleep disturbance and improves functionality in fibromyalgia: results from a 14-week, randomized, double-blind, placebo-controlled study. Pain 2011;152:1007–17.
Khedr EM, Omran EAH, Ismail NM, et al. Effects of transcranial direct current stimulation on pain, mood and serum endorphin level in the treatment of fibromyalgia: a double blinded, randomized clinical trial. Brain Stimul 2017;10:893–901.
Amer-Cuenca JJ, Pecos-Martin D, Martinez-Merinero P, et al. How much is needed? Comparison of the effectiveness of different pain education dosages in patients with fibromyalgia. Pain Med 2019;20:961–70.
Substance Nomenclature:
0 (Placebos)
Entry Date(s):
Date Created: 20201229 Date Completed: 20210112 Latest Revision: 20210323
Update Code:
20240105
PubMed Central ID:
PMC7748312
DOI:
10.1097/MD.0000000000023785
PMID:
33371148
Czasopismo naukowe
Background: To evaluate the effectiveness of non-invasive neuro-adaptive electrostimulation (NAE) therapy for treating chronic pain and disability in patients with fibromyalgia.
Method/design: A prospective, randomized, sham-controlled study was conducted in 37 women with fibromyalgia. Participants were randomly assigned to receive either active NAE (n = 20) or stimulation with a sham device (n = 17). Participants in the experimental arm received eight 30-minute sessions over 4 weeks (2 sessions per week). The sham group received eight 30-minute sessions of sham stimulation. Therapeutic effects on pain relief, disability, and quality of life were evaluated using outcome measures at baseline, at 4 weeks, and after 3 months' follow-up.
Results: The findings indicated a significant reduction of pain in the active NAE group compared with the sham group immediately post-intervention, with a difference on the Visual Analog Scale (VAS) of 3 points (P = .001), and at 3 months' follow-up (P = .02). There were significant intragroup differences between the groups (P < .05) at post-intervention. After the intervention, both groups presented significant reductions on the Fibromyalgia Impact Questionnaire (FIQ) with respect to baseline (P = .004), but not at the 3-month follow-up. In the conditioned pain modulation (CPM) in thumb variable we found significant differences between the groups at the 3-month follow-up (P = .02). No additional benefits for conditioned pain modulation and disability were observed between groups at the 3-month follow-up. Furthermore, anxiety/depression and catastrophizing improved in both groups, but no differences between groups were found.
Conclusions: In this fibromyalgia cohort, NAE therapy significantly improved pain and quality of life at 4 weeks, but not at 3-month follow-up, compared with the sham stimulation group. Future investigations are needed in larger populations to confirm these findings.
Competing Interests: The authors have no conflicts of interest to disclose.
(Copyright © 2020 the Author(s). Published by Wolters Kluwer Health, Inc.)

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies